Nicholas B. Hawkins, VP and Chief Financial Officer of Arteris, Inc., filed a Form 4 on August 14, 2026, disclosing a series of transactions in the company's common stock and a non-qualified stock option between August 12 and August 13, 2026.

Key Highlights

  • Sale on August 12: Hawkins disposed of 200 shares of common stock at $29 per share, reducing his direct holdings to 102,972 shares.
  • Option exercise on August 13: Hawkins acquired 3,125 shares via exercise of a non-qualified stock option at an exercise price of $9.28 per share, bringing holdings to 106,097 shares.
  • Sale on August 13: Hawkins disposed of 10,431 shares at a weighted average price of $28.2646, with individual sale prices ranging from $28.26 to $28.38 inclusive.
  • Remaining direct ownership: Following all reported transactions, Hawkins directly held 95,666 shares of common stock.
  • Remaining derivative securities: After the option exercise, Hawkins retained 31,250 non-qualified stock options with an exercise price of $9.28 and an expiration date of February 20, 2035.
  • Vesting schedule: The non-qualified stock options vest in 16 equal quarterly installments of 1/16th each, beginning on April 1, 2025, according to the filing.

Arteris CFO Transaction Details: Option Exercise and Open-Market Sales

According to the filing, Nicholas B. Hawkins, identified as VP and Chief Financial Officer of Arteris, Inc. (NASDAQ:AIP), reported three separate transactions across two trading days. On August 12, 2026, Hawkins disposed of 200 shares of common stock at $29 per share through a sale coded "S," leaving him with a direct beneficial ownership of 102,972 shares.

On August 13, 2026, Hawkins exercised a non-qualified stock option, acquiring 3,125 shares at the exercise price of $9.28 per share, coded "M" in the filing. The same day, he disposed of 10,431 shares coded "S" at a weighted average sale price of $28.2646. The filing notes these shares "were sold in multiple transactions at prices ranging from $28.26 to $28.38 inclusive," and states that Hawkins undertakes to provide full detail on per-price share counts upon request. Following these transactions, his direct beneficial ownership stood at 95,666 shares of common stock.

In Table II, the filing discloses that the exercised options were part of a non-qualified stock option grant with an exercise price of $9.28, an expiration date of February 20, 2035, and a vesting schedule of 16 equal quarterly installments of 1/16th each beginning April 1, 2025. The price of the derivative security at exercise is listed as $0.00. After the exercise, Hawkins retained 31,250 non-qualified stock options. The form was signed by Paul Alpern as Attorney-in-Fact for Hawkins Nicholas B. and dated August 14, 2026.

What Was Disclosed

The filing reports three transactions by Arteris, Inc.'s CFO between August 12 and August 13, 2026, including two open-market sales totaling 10,631 shares and one stock option exercise of 3,125 shares, resulting in direct beneficial ownership of 95,666 shares.